Navigation Links
Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
Date:9/7/2007

- First Patient Enrolled in Second of Two Phase 3 Trials

- More Than 100 Patients Enrolled in First Phase 3 Trial - Trial Design Was Reviewed Under Special Protocol Assessment Procedure

With The FDA

IRVINE, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc., (Nasdaq: SPPI) today announced today that it has begun enrolling patients in its second pivotal Phase 3 registrational trial for EOquin, the Company's drug candidate for non-invasive bladder cancer. The trial design was reviewed under a previously announced Special Protocol Assessment procedure, which calls for two double-blind, placebo-controlled, randomized clinical trials.

"The initiation of our second pivotal Phase 3 trial for EOquin in non-invasive bladder cancer patients demonstrates the significant progress we are making with this program," stated Rajesh C. Shrotriya, M.D., Chairman, President and CEO of Spectrum Pharmaceuticals. "Non-invasive bladder cancer is the fifth most common cancer, with a incidence of more than 67 thousand in the U.S. and more than 147 thousand in Europe. Because bladder cancer is typically not lethal, it is estimated that there are more than 500 thousand people suffering from bladder cancer in the United States and more than 935 thousand in Europe. If approved, EOquin may help the many patients suffering from this disease."

The EOquin study calls for two double blind, placebo-controlled, randomized Phase 3 clinical trials, in patients with non-invasive bladder cancer. Patients will be randomized in a one-to-one ratio to EOquin or placebo. The primary endpoint will be the difference in the rate of tumor recurrence between the two treatmen
'/>"/>

SOURCE Spectrum Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Tech Digest: Firstlogic, Fiserv, Red Prairie, Spectrum Brands, Associated Bank
2. Deltanoid Pharmaceuticals begins phase II osteoporosis study
3. The Coming of Biotech Generic Pharmaceuticals
4. Use of the PROTEAN Plus Dodeca Cell for Second-Dimension SDS-PAGE, Rev A
5. In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate
6. CIOs looking to hire more IT workers in second quarter
7. DNASTAR catches second wave of sequencing
8. 9 tips for making 90 seconds count in an investment pitch
9. City of Hope adds second TomoTherapy system
10. UW-Madison hybrid-vehicle team places second nationally
11. Just one nanosecond: Clocking events at the nanoscale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , January 15, 2014 A study has ... on the Formula 1 track could help to tackle the ... Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) and ... provider Simplyhealth. Telemetry technology, which is inspired by ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Two champions ... continued their sponsorship of an annual competition for middle ... and access to, innovative STEM study. The competition presents ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
(Date:1/15/2014)... DTS Language Services, Inc . is ... for Life Science organizations who need document translations. Clients ... of their documents in advance with a selection of nearly ... translations, often a critical factor in clinical and scientific fields, ...
(Date:1/15/2014)... CA (PRWEB) January 15, 2014 ... research solutions, today announced that Lupin Limited, one of ... Freeslate’s CM Protégé PharmD System for high ... Mumbai, India, is focused on a wide range of ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5DTS Improves Efficiency for Life Science Document Translations 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3
... show of ... supporters, gains momentum, PITTSBURGH, July ... future, finding an advantage amidst global,competition requires finding new and ... does just,that, and will help secure that edge., The ...
... /Xinhua-PRNewswire/ -- Over 300 of,China,s top stem cell ... latest results and held China,s first ever symposium ... the just,concluded first annual 2008 China Stem Cell ... Taizhou, China. At the Forum, which was chaired ...
... Geoffrey Allan Will Discuss Company,s IPLEX(TM) Program in Myotonic ... ... Inc. (Nasdaq:,INSM) a developer of follow-on biologics and biopharmaceuticals, today,announced that ... Drug Discovery and Development of Innovative Therapeutics on,Thursday, August 7th, 2008 ...
Cached Biology Technology:Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 2Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 3Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 2Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 3Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 4Insmed CEO to Present at Drug Discovery & Development Conference 2
(Date:7/10/2014)... ANN ARBOR Because the strong currents in the ... rupture of the oil pipeline beneath the channel would ... and Huron, according to a new University of Michigan ... one scenario examined in the study and accompanying animations, ... and Round Island after 12 hours and Bois Blanc ...
(Date:7/10/2014)... Anoplolepis gracilipes is ranked amongst the top 100 worst ... on islands. A new study published in the open access ... effects and dangers of the introduction of the yellow crazy ... of the Valle de Mai, a UNESCO World Heritage Site, ... Mai is a unique ecosystem containing many endemic species, including ...
(Date:7/10/2014)... YORK, NY (July 10, 2014) Columbia University Medical ... personalized gene therapies for patients with retinitis pigmentosa (RP), ... first of its kind, takes advantage of induced pluripotent ... retinal cells, which are then used as a patient-specific ... this approach, researchers led by Stephen H. Tsang, MD, ...
Breaking Biology News(10 mins):Straits of Mackinac 'worst possible place' for a Great Lakes oil spill 2Straits of Mackinac 'worst possible place' for a Great Lakes oil spill 3Invasion of yellow crazy ant in a Seychelles UNESCO palm forest: Threats and solutions 2Patient-specific stem cells and personalized gene therapy 2Patient-specific stem cells and personalized gene therapy 3
... the world, nitrogen compounds are released to the ... fuels. These pollutants are deposited to ecosystems as ... miles downwind of their release point. The Catskill ... in pointthough they contain little in the way ...
... BIRMINGHAM, Ala. The newest generation of compact research ... boosted the scientific capacity of the International Space Station ... Birmingham (UAB). A UAB-designed cryogenic freezer called GLACIER, ... made its NASA debut in late 2008 aboard a ...
... DC Fascinating scientific advances across the spectrum ... be featured and explained through engaging table-top exhibits ... 15th Annual Exhibition & Reception. The exhibition/reception will ... March 24, in Rooms B338-340 of the Rayburn ...
Cached Biology News:Tree species composition influences nitrogen loss from forests 2Science returns to the Capitol Hill spotlight at March 24 exhibition 2Science returns to the Capitol Hill spotlight at March 24 exhibition 3Science returns to the Capitol Hill spotlight at March 24 exhibition 4
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
... Since the Flp-In System creates ... produce equivalent levels of the protein ... demonstrated in Figure 3 (click link ... sequence for chloramphenicol-acetyl transferase (CAT) was ...
... Multiple solvents can be used, such as water, benzene, formamide, nitrobenzene, cyclohexane, 1,4-dioxane, p-xylene, dimethyl sulfoxide, ... * Range: 12-position switchable: ... ... ...
Fast, sensitive quantitation of total MEK 1/2 concentration....
Biology Products: